Akèy › Kansè Poumon ki pa ti selil › Michigan › Flint
Etid klinik pou Kansè Poumon ki pa ti selil nan Flint, MI
9 etid pou Kansè Poumon ki pa ti selil ap chèche patisipan nan sit nan ak bò kote Flint (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.
Tèks ofisyèl etid la (Anglè)
Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →
Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])
Ap rekriteFaz 3
- Cancer Hematology Centers - Flint, Flint
- Genesys Hurley Cancer Institute, Flint
- Hurley Medical Center, Flint
Immunotherapy After Surgery for People Who Have No Remaining Cancer Cells After Standard Treatment for Early-Stage Non-Small Cell Lung Cancer, INSIGHT Trial
Ap rekriteFaz 3
- Cancer Hematology Centers - Flint, Flint
- Genesys Hurley Cancer Institute, Flint
Testing Osimertinib as a Treatment for Lung Cancers With an EGFR Exon 20 Change
Ap rekriteFaz 2
- Cancer Hematology Centers - Flint, Flint
- Genesee Hematology Oncology PC, Flint
- Genesys Hurley Cancer Institute, Flint
- ak 1 plis
Testing Proton Craniospinal Radiation Therapy Versus the Usual Radiation Therapy for Leptomeningeal Metastasis, RADIATE-LM Trial
Ap rekriteFaz 3
- McLaren Cancer Institute-Flint, Flint
Comparing Combinations of Targeted Drugs for Advanced Non-Small Cell Lung Cancer That Has EGFR and MET Gene Changes (A Lung-MAP Treatment Trial)
Ap rekriteFaz 2
- Cancer Hematology Centers - Flint, Flint
- Genesys Hurley Cancer Institute, Flint
- Hurley Medical Center, Flint
Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has Increased Copies of the MET Gene (An Expanded Lung-MAP Treatment Trial)
Ap rekriteFaz 2
- Cancer Hematology Centers - Flint, Flint
- Genesys Hurley Cancer Institute, Flint
- Hurley Medical Center, Flint
Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has a MET Exon 14 Skipping Gene Change (An Expanded Lung-MAP Treatment Trial)
Ap rekriteFaz 2
- Cancer Hematology Centers - Flint, Flint
- Genesys Hurley Cancer Institute, Flint
- Hurley Medical Center, Flint
Adding the Immunotherapy Drug Cemiplimab to Usual Treatment for People With Advanced Non-Small Cell Lung Cancer Who Had Previous Treatment With Platinum Chemotherapy and Immunotherapy (An Expanded Lung-MAP Treatment Trial)
Ap rekriteFaz 2/3
- Cancer Hematology Centers - Flint, Flint
- Genesys Hurley Cancer Institute, Flint
Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics
Ap rekriteEtid obsèvasyon
- Cancer Hematology Centers - Flint, Flint
- Genesee Hematology Oncology PC, Flint
Etid Kansè Poumon ki pa ti selil nan lòt vil
- Houston, TX145 etid
- New York City, NY120 etid
- Arlington, VA104 etid
- Nashville, TN97 etid
- Boston, MA90 etid
- Los Angeles, CA87 etid
- St. Louis, MO73 etid
- Chicago, IL61 etid
- Baltimore, MD60 etid
- San Antonio, TX59 etid
- Columbus, OH56 etid
- Washington, DC55 etid
Lòt etid nan Flint
- Kansè poumon10 etid
- Kansè nan tete9 etid
- Kansè pwostat7 etid
- Kansè kolorektal6 etid
- Leksemi mieloïd egi6 etid
- Kansè (tout kalite)5 etid
- Lupus4 etid
- Karsinòm selil skuamèz tèt ak kou4 etid
- Kansè Ipofaringe4 etid
- Kansè larinks4 etid
- Kansè bouch4 etid
- Kansè renn (Kasinom selil renn)3 etid
Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.